首页> 外文期刊>Science >Navigating Biotech/Pharma Mergers and Acquisitions
【24h】

Navigating Biotech/Pharma Mergers and Acquisitions

机译:导航生物技术/制药业合并与收购

获取原文
获取原文并翻译 | 示例
       

摘要

Years ago when Sugen, a company focused on protein kinase inhibitors, was bought by Pfizer, over 300 people lost their jobs, but not their sense of humor. These intrepid scientists held wave parties to announce the latest round of scientists that were given severance pay and let go. But these were not pity parties in the least-most went on to equally lucrative, or even better, positions in other companies. Mergers and acquisitions might sound daunting, but those who work in the biotechnology/pharmaceutical arena know it as a fact of life. Researchers who are interested in entering this fast-paced world need to learn how to "ride the wave" and always keep their eye out for other opportunities. In short, they need to take advice from the cover of Douglas Adams' "Hitchhiker's Guide to the Galaxy" series: "Don't Panic."
机译:几年前,辉瑞(Pfizer)收购了一家专注于蛋白激酶抑制剂的公司Sugen,有300多人失业,但没有幽默感。这些勇敢的科学家举行了狂欢派对,宣布获得了遣散费并放手的最新一轮科学家。但是,这些并不是最可怜的政党,他们在其他公司中的地位同样有利可图,甚至更好。合并和收购听起来可能令人生畏,但在生物技术/制药领域工作的人都知道这是生活的事实。对进入这个快节奏世界感兴趣的研究人员需要学习如何“驾驭潮流”,并时刻关注其他机会。简而言之,他们需要从道格拉斯·亚当斯(Douglas Adams)的“银河旅行者指南”系列的封面中寻求建议:“不要惊慌”。

著录项

  • 来源
    《Science》 |2012年第6086期|p.1335|共1页
  • 作者

    Jacqueline Ruttimann Oberst;

  • 作者单位
  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:53:29

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号